Literature DB >> 15236874

Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold.

Anders N Pedersen1, Stine Korreman, Håkan Nyström, Lena Specht.   

Abstract

BACKGROUND AND
PURPOSE: Adjuvant radiotherapy of breast cancer using wide tangential photon fields implies a risk of late cardiac and pulmonary toxicity. This CT-study evaluates the detailed potential dosimetric consequences of applying breathing adapted radiotherapy (BART), and the feasibility of a monitored voluntary breath-hold technique for right-sided as well as for left-sided tumours. PATIENTS AND METHODS: After breast-conserving surgery, 16 patients were CT-scanned in distinct respiratory phases using the varian real-time position management system for the monitoring of respiratory anterioposterior chest wall excursion. Each patient underwent three scans: during free breathing (FB), voluntary expiration breath-hold (EBH) and voluntary deep inspiration breath-hold (DIBH). For each scan, an optimised treatment plan was designed with conformal tangential fields encompassing the clinical target volume (CTV) of the breast and ipsilateral internal mammary nodes, and an anterior supraclavicular field.
RESULTS: Breath-hold was well accepted by the patients, with a median duration of 24 s for both EBH and DIBH. The mean anterioposterior chest wall excursions were 2.5, 2.6 and 4.1 mm during FB, EBH and DIBH, respectively. During EBH, the mean front chest wall position was 2.7 mm posterior to its mid-FB position, and during DIBH 12.6 mm anterior to its mid-FB position. For right-sided tumours, the median ipsilateral relative lung volume receiving >50% of the prescribed CTV dose was 39, 49 and 32% for FB, EBH and DIBH, respectively. For left-sided tumours, the corresponding percentages were 37, 46 and 31%. The median heart volume receiving >50% of the prescription dose was reduced from 8% for FB to 1% for DIBH, and the median left anterior descending coronary artery volume was reduced from 54 to 5%.
CONCLUSIONS: Irradiated cardiac volumes can consistently be reduced for left-sided breast cancers using DIBH for wide tangential treatment fields. Additionally, substantial dose reductions in the lung are observed for both right- and left-sided tumours.

Entities:  

Mesh:

Year:  2004        PMID: 15236874     DOI: 10.1016/j.radonc.2004.03.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  45 in total

1.  Evaluation of dose to cardiac structures during breast irradiation.

Authors:  M C Aznar; S-S Korreman; A N Pedersen; G F Persson; M Josipovic; L Specht
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

2.  Reduction of cardiac and coronary artery doses in irradiation of left-sided breast cancer during inspiration breath hold : A planning study.

Authors:  S Schönecker; C Heinz; M Söhn; W Haimerl; S Corradini; M Pazos; C Belka; H Scheithauer
Journal:  Strahlenther Onkol       Date:  2016-09-08       Impact factor: 3.621

3.  Selection of patients with left breast cancer for deep-inspiration breath-hold radiotherapy technique: Results of a prospective study.

Authors:  Beata Czeremszyńska; Stanisław Drozda; Michał Górzyński; Lucyna Kępka
Journal:  Rep Pract Oncol Radiother       Date:  2017-06-30

4.  Joint Estimation of Cardiac Toxicity and Recurrence Risks After Comprehensive Nodal Photon Versus Proton Therapy for Breast Cancer.

Authors:  Line B Stick; Jen Yu; Maja V Maraldo; Marianne C Aznar; Anders N Pedersen; Søren M Bentzen; Ivan R Vogelius
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-13       Impact factor: 7.038

5.  On the dosimetric impact of inhomogeneity management in the Acuros XB algorithm for breast treatment.

Authors:  Antonella Fogliata; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2011-08-26       Impact factor: 3.481

Review 6.  Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.

Authors:  Umberto Campia; Javid J Moslehi; Laleh Amiri-Kordestani; Ana Barac; Joshua A Beckman; David D Chism; Paul Cohen; John D Groarke; Joerg Herrmann; Carolyn M Reilly; Neal L Weintraub
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

Review 7.  Cardiac Toxicity after Radiotherapy for Breast Cancer: Myths and Facts.

Authors:  Mirko Nitsche; René Pahl; Karen Huber; Kirsten Eilf; Juergen Dunst
Journal:  Breast Care (Basel)       Date:  2015-04       Impact factor: 2.860

8.  Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning.

Authors:  S Vennarini; N Fournier-Bidoz; C Aristei; C E de Almeida; V Servois; F Campana; V Mosseri; A Fourquet; Y M Kirova
Journal:  Br J Radiol       Date:  2013-02-25       Impact factor: 3.039

9.  Respiratory motion of the heart and positional reproducibility under active breathing control.

Authors:  Reshma Jagsi; Jean M Moran; Marc L Kessler; Robin B Marsh; James M Balter; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-01       Impact factor: 7.038

10.  Advances in radiation therapy dosimetry.

Authors:  Bhudatt Paliwal; Dinesh Tewatia
Journal:  J Med Phys       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.